|
Attempted contact with initial reporter (b)(6) 2026 4:42pm called (b)(6) - per information provided from the medtronic product event summary report attempted contact with initial reporter (b)(6) 2026 11:29am called (b)(6) - followed voice prompts to "records" and left a voice message initial review of product event summary (b)(4) determined the adverse event was not "caused" by the implant.The implant is intended to be used with supplemental fixation.The supplemental fixation of 2 medtronic bone screws were loosened and backed out.Contacted medtronic rep.And post-operative trauma is unknown, bone quality measures before initial implant were unknown, and the same surgeon performed implant and explant.Investigation details:the adaptix¿ peek interbody system with nanotechnology devices and the capstone control¿ peek spinal system with nanotechnology devices including those with macro-, micro- and nano-roughened surface textured features are intended for spinal fusion procedures in skeletally mature patients with degenerative disc disease (defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies) at one or two contiguous spinal levels from l2-s1.These patients should have had six months of nonoperative treatment.These patients may have had a previous non-fusion spinal surgery and/or may have up to grade 1 spondylolisthesis or retrolisthesis at the involved spinal level(s).Additionally, adaptix¿ peek interbody system with nanotechnology and the capstone control¿ peek spinal system with nanotechnology devices can be used as an adjunct to fusion in patients diagnosed with degenerative scoliosis.The adaptix¿ peek and the capstone control¿ peek devices are to be used with autograft and/or allograft comprised of cancellous and/or corticocancellous bone graft and/or demineralized allograft bone with bone marrow aspirate.These implants are intended for use with supplemental fixation indicated for lumbar spinal fusion procedures and may be implanted via an open or a minimally invasive posterior approach and/or transforaminal approach.
|